ZKZoltán Klárik

Zoltán Klárik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zoltán Klárik has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Péter Hegyi

    Centre for Translational Medicine, Semmelweis University, Budapest, Hungary

    2 shared publications
  • András Czébely-Lénárt

    Centre for Translational Medicine, Semmelweis University, Budapest, Hungary

    1 shared publication
  • Anett Rancz

    Centre for Translational Medicine, Semmelweis University, Budapest, Hungary

    1 shared publication
  • Attila Szijártó

    Centre for Translational Medicine, Semmelweis University, Budapest, Hungary

    1 shared publication
  • Boglárka Lilla Szentes

    Centre for Translational Medicine, Semmelweis University, Budapest, Hungary

    1 shared publication
  • Dóra Léna Fedorcsák

    Centre for Translational Medicine, Semmelweis University, Budapest, Hungary

    1 shared publication

Latest Publications

  • Open Access

    Evaluating oncoplastic breast-conserving surgery: oncological safety, risks, and satisfaction—a systematic review and meta-analysis

    by Loretta Enikő Nyirády, András Czébely-Lénárt, Jakub Hoferica, Péter Hegyi, Péter Fehérvári, Péter Nyirády, Péter Riesz, Nándor Ács, Attila Szijártó, Zoltán Klárik

    Oncoplastic breast-conserving surgery (OBCS) comprises diverse techniques aimed at enhancing aesthetic outcomes and safety in breast cancer treatment. However, a knowledge gap exists in understanding the comprehensive assessment of safety factors and satisfaction rates associated with OBCS techniques. This systematic review and meta-analysis aim to compare volume displacement (VD) and volume replacement (VR) techniques concerning oncological safety, complication rates and patient satisfaction. A systematic literature search was conducted in three databases—PubMed, Embase, and Cochrane Library (CENTRAL)—up to November 2023. Original articles with quantitative satisfaction rates, recurrence, re-excision, margin status, and complications (hematoma, seroma, wound infection, fat necrosis). The systematic search identified 17,374 records, with 80 eligible studies and 46 providing quantitative data. Results showed comparable oncological safety between VD and VR techniques, including similar recurrence (Prop: 0.02; CI 0.02–0.03) and re-excision rates (Prop: 0.05; CI 0.04–0.07). VR techniques had a higher incidence of fat necrosis (Prop: 0.07; CI 0.04–0.12). Overall satisfaction was high (Prop: 0.83; CI 0.78–0.87), with VD yielding the highest satisfaction (Prop: 0.93; CI 0.85–0.97). Oncoplastic breast-conserving surgery emerges as a successful approach for treating early-stage breast cancer, characterized by low associated risks and high satisfaction rates.


  • Open Access

    The significance of perioperative glucocorticoids in the prevention of seroma formation after mastectomies: a systematic review and meta-analysis

    by Levente Doleviczényi, Lőrinc Frivaldszky, Anett Rancz, Dóra Léna Fedorcsák, Boglárka Lilla Szentes, Péter Hegyi, Zoltán Klárik

    Purpose: Seroma formation is one of the most common complications after mastectomy. Seromas can lead to repeated aspirations, increase the risk of infection, and potentially delay oncologic treatment. Several strategies have recently been employed to prevent seromas, but there is no definitive standard. We aim to determine whether perioperative glucocorticoids (GC) are safe and effective in preventing seromas in patients undergoing mastectomy. Methods: We performed a systematic search in five databases on November 12, 2024. Eligible studies included women who underwent mastectomy and received perioperative GCs. Results are reported as risk ratios (RR), odds ratios (OR), or mean differences (MDs) with 95% confidence intervals (CIs), and are presented as forest plots. A random-effects model was used to pool effect sizes. Results: Altogether, 13 studies (12 RCTs and 1 case–control study) with 1011 patients were included; all were eligible for meta-analysis. The rate of seroma formation was significantly lower in the GC groups compared to the placebo groups (RR = 0.56, CI 0.38; 0.82, p = 0,008). Total volume of drainage (MD = -213.36 ml, CI -312.5; -114.22, p = 0.001) and days to drain removal (MD =—3.01 days, CI -4.06; -1.96, p = 0.001) were also lower in the GC groups. The rate of wound infection showed a higher trend in the intervention groups (RR = 1.26, CI 0.82; 1.92, p = 0.224), although the results did not reach statistical significance, Conclusions: Our results suggest that perioperative glucocorticoid administration may reduce seroma formation in patients undergoing mastectomy. A potential increase in wound infection rates was also observed, but this requires further investigation.